Primary aldosteronism: a common cause of resistant hypertension.
作者信息
Kline Gregory A, Prebtani Ally P H, Leung Alexander A, Schiffrin Ernesto L
机构信息
Department of Endocrinology (Kline, Leung), University of Calgary, Calgary, Alta.; Department of Internal Medicine, Endocrinology and Metabolism (Prebtani), McMaster University, Hamilton, Ont.; Department of Medicine (Schiffrin), Jewish General Hospital and Lady Davis Research Institute, McGill University, Montréal, Que.
出版信息
CMAJ. 2017 Jun 5;189(22):E773-E778. doi: 10.1503/cmaj.161486.
Abstract
摘要
相似文献
1
Primary aldosteronism: a common cause of resistant hypertension.
CMAJ. 2017 Jun 5;189(22):E773-E778. doi: 10.1503/cmaj.161486.
2
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
Clin Endocrinol (Oxf). 2003 Oct;59(4):427-30. doi: 10.1046/j.1365-2265.2003.01841.x.
3
Primary aldosteronism: revival of a syndrome.
J Hypertens. 2001 Mar;19(3):363-6. doi: 10.1097/00004872-200103000-00002.
4
[Primary aldosteronism].
Rev Med Chil. 2008 Jul;136(7):905-14. Epub 2008 Sep 4.
5
The current epidemic of primary aldosteronism: causes and consequences.
J Hypertens. 2004 Oct;22(10):2039-40; author reply 2040. doi: 10.1097/00004872-200410000-00032.
6
The current epidemic of primary aldosteronism: causes and consequences.
J Hypertens. 2004 Oct;22(10):2040-2. doi: 10.1097/00004872-200410000-00034.
7
Primary aldosteronism.
Urol Clin North Am. 1977 Jun;4(2):227-37.
8
Cautions over the current epidemic of primary aldosteronism.
Lancet. 2001 Mar 24;357(9260):953-4. doi: 10.1016/S0140-6736(00)04223-9.
9
Primary aldosteronism: emerging trends.
Trends Endocrinol Metab. 2013 Sep;24(9):421-30. doi: 10.1016/j.tem.2013.05.003. Epub 2013 Jun 21.
10
Primary aldosteronism: management issues.
Ann N Y Acad Sci. 2002 Sep;970:61-76. doi: 10.1111/j.1749-6632.2002.tb04413.x.
引用本文的文献
1
Evaluation of Predictive Risk Factors of Persistent Hypertension in Hyperaldosteronism After Surgery.
Int J Endocrinol Metab. 2025 Apr 30;23(2):e156728. doi: 10.5812/ijem-156728.
2
Total or partial adrenalectomy for aldosterone-producing adenoma: can Ga-Pentixafor PET/CT predict surgical outcomes?
Eur J Nucl Med Mol Imaging. 2025 Apr 4. doi: 10.1007/s00259-025-07244-9.
3
Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess.
Eur J Endocrinol. 2025 Mar 3;192(3):191-201. doi: 10.1093/ejendo/lvaf019.
4
Clinical practice guideline for the management of hypertension in China.
Chin Med J (Engl). 2024 Dec 20;137(24):2907-2952. doi: 10.1097/CM9.0000000000003431. Epub 2024 Dec 9.
5
Cutoff Values of Aldosterone and the Aldosterone-Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study.
J Cardiovasc Dev Dis. 2024 Sep 27;11(10):299. doi: 10.3390/jcdd11100299.
6
Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review.
Int J Surg. 2024 Nov 1;110(11):7367-7380. doi: 10.1097/JS9.0000000000002048.
7
Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout.
Front Endocrinol (Lausanne). 2024 Jul 30;15:1424207. doi: 10.3389/fendo.2024.1424207. eCollection 2024.
8
Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk.
Front Endocrinol (Lausanne). 2024 May 14;15:1373862. doi: 10.3389/fendo.2024.1373862. eCollection 2024.
9
Commensal microbiota regulate aldosterone.
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1032-F1038. doi: 10.1152/ajprenal.00051.2024. Epub 2024 Apr 18.
10
Adrenal Vein Sampling in the Management of Primary Aldosteronism: The Added Value of Intraprocedural Cortisol Assessment.
Int J Endocrinol. 2023 Dec 21;2023:5563881. doi: 10.1155/2023/5563881. eCollection 2023.
本文引用的文献
1
Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.
J Clin Hypertens (Greenwich). 2016 Dec;18(12):1205-1212. doi: 10.1111/jch.12916. Epub 2016 Oct 19.
2
Effects of Treating Primary Aldosteronism on Renal Function.
J Clin Hypertens (Greenwich). 2017 Mar;19(3):290-295. doi: 10.1111/jch.12914. Epub 2016 Sep 23.
3
Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.
J Clin Endocrinol Metab. 2016 Nov;101(11):3989-3996. doi: 10.1210/jc.2016-1963. Epub 2016 Jul 18.
4
Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.
J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35. doi: 10.1210/jc.2016-1472. Epub 2016 May 12.
5
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
6
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2016 May;101(5):1889-916. doi: 10.1210/jc.2015-4061. Epub 2016 Mar 2.
7
Epidemiology of Hypertension in Canada: An Update.
Can J Cardiol. 2016 May;32(5):687-94. doi: 10.1016/j.cjca.2015.07.734. Epub 2015 Aug 15.
8
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20.
9
Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
J Clin Endocrinol Metab. 2015 Nov;100(11):4339-47. doi: 10.1210/jc.2015-2752. Epub 2015 Sep 24.
10
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.
Eur J Endocrinol. 2015 Nov;173(5):665-75. doi: 10.1530/EJE-15-0450. Epub 2015 Aug 26.
Zotero 插件